Management of cardiac complications in patients with thalassemia major.
Vecchio
C
C
E.O. Ospedali Galliera, Cardiology Division, Genova, Italy.
Derchi
G
G
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D002316:Cardiotonic Agents / Q000627:therapeutic use; D015913:Chelation Therapy; D003131:Combined Modality Therapy; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D006333:Heart Failure / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D016027:Heart Transplantation; D006432:Hemochromatosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D065227:Transfusion Reaction; D014462:Ultrafiltration; D014665:Vasodilator Agents / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000150:complications* / Q000628:therapy
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents